Summary of Significant Accounting Policies (Details) - Schedule of antidilutive due to the net loss - shares	12 Months Ended
Dec. 31, 2021	Dec. 31, 2020
Stock options [Member]
Equivalent common shares
Equivalent common shares	669,067	486,101
Warrants [Member]
Equivalent common shares
Equivalent common shares	18,436	5,056
RRD note conversion [Member]
Equivalent common shares
Equivalent common shares		49,897

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration